Pressure BioSciences provides progress report on UltraShear Nano-CBD launch

Pressure BioSciences provides the market with updates on their launch progress and commercialization program for their revolutionary, best-in-class Nano-CBD product, manufactured with PBIO‘s proprietary UltraShear technology platform. Since the press release of August 9, the Company has received commitments from an additional five new distributors, initially reflecting expected incremental 2023 revenues of between $200K and $250K. These new distributors consist of both on-line marketers and distributors who supply to their own dispensaries. This group alone represents over 345 dispensaries, and anticipated reorders are expected to significantly increase 2023 revenues beyond the initial purchase quantities.